X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.310
+0.170 (4.11%)
At close: May 29, 2026, 4:00 PM EDT
4.400
+0.090 (2.09%)
After-hours: May 29, 2026, 5:22 PM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 45 employees as of December 31, 2025. The number of employees decreased by 98 or -68.53% compared to the previous year.
Employees
45
Change (1Y)
-98
Growth (1Y)
-68.53%
Revenue / Employee
$200,311
Profits / Employee
-$2,216,044
Market Cap
406.52M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -98 | -68.53% |
| Dec 31, 2024 | 143 | 50 | 53.76% |
| Dec 31, 2023 | 93 | 23 | 32.86% |
| Dec 31, 2022 | 70 | -13 | -15.66% |
| Dec 31, 2021 | 83 | 11 | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Replimune Group | 479 |
| Puma Biotechnology | 179 |
| Lyell Immunopharma | 161 |
| Enanta Pharmaceuticals | 120 |
| Artiva Biotherapeutics | 104 |
| Verastem | 102 |
| OmniAb | 89 |
XFOR News
- 2 days ago - X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 22 days ago - X4 Pharmaceuticals reports Q1 EPS (16c), consensus (20c) - TheFly
- 22 days ago - X4 Pharmaceuticals files $300M mixed securities shelf - TheFly
- 23 days ago - X4 Pharmaceuticals Registration statement: Registration filing - Filings
- 23 days ago - X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 23 days ago - X4 Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 23 days ago - X4 Pharmaceuticals Earnings release: Q1 2026 - Filings
- 4 weeks ago - X4 Pharmaceuticals announces EC approval of Xolremdi - TheFly